Literature DB >> 24421520

Oxymetazoline (topical): rosacea.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Entities:  

Year:  2013        PMID: 24421520      PMCID: PMC3839519          DOI: 10.1310/hpj4807-558

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  6 in total

1.  Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.

Authors:  Jonathan Wilkin; Mark Dahl; Michael Detmar; Lynn Drake; Alvan Feinstein; Richard Odom; Frank Powell
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

2.  Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.

Authors:  Stuart D Shanler; Andrew L Ondo
Journal:  Arch Dermatol       Date:  2007-11

Review 3.  Systematic review of rosacea treatments.

Authors:  Esther J van Zuuren; Aditya K Gupta; Melissa D Gover; Mark Graber; Sally Hollis
Journal:  J Am Acad Dermatol       Date:  2006-11-07       Impact factor: 11.527

4.  Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group.

Authors:  B E Elewski; Z Draelos; B Dréno; T Jansen; A Layton; M Picardo
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-06-25       Impact factor: 6.166

5.  American Acne & Rosacea Society rosacea medical management guidelines.

Authors:  James Q Del Rosso; Hilary Baldwin; Guy Webster
Journal:  J Drugs Dermatol       Date:  2008-06       Impact factor: 2.114

Review 6.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563

  6 in total
  1 in total

Review 1.  Recent advances in the understanding and management of rosacea.

Authors:  Uwe Wollina
Journal:  F1000Prime Rep       Date:  2014-07-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.